Göran Wålinder

Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries

A. Vangsted, I. Turesson, C. Blimark, 2021, European journal of haematology.

Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population‐based data from the Swedish Myeloma Register

U. Mellqvist, O. Linder, G. Juliusson, 2017, European journal of haematology.

Flow Cytometric Measurement of Blood Cells with BCR-ABL 1 Fusion Protein in Chronic Myeloid Leukemia

J. Dahlin, U. Olsson‐Strömberg, R. Rosenquist, 2017 .

Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study

G. Juliusson, H. Nahi, I. Turesson, 2021, Cancer reports.

Outcome and characteristics of non‐measurable myeloma: A cohort study with population‐based data from the Swedish Myeloma Registry

U. Mellqvist, O. Linder, G. Juliusson, 2019, European Journal of Haematology.

Upfront bortezomib, lenalidomide, and dexamethasone compared to bortezomib, cyclophosphamide, and dexamethasone in multiple myeloma

G. Gahrton, R. Månsson, H. Nahi, 2019, European journal of haematology.

Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia

Ulf Landegren, Masood Kamali-Moghaddam, Linda Arngården, 2017, Scientific Reports.

Flow Cytometric Measurement of Blood Cells with BCR-ABL1 Fusion Protein in Chronic Myeloid Leukemia

J. Dahlin, U. Olsson‐Strömberg, U. Landegren, 2017, Scientific Reports.